Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Thomas

Showing results (1241-1250 of 1,275) with videos related to

Pageof 128
Sort By:
Cell Reports. Medicine|October 8, 2022
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patientsThomas J LaSalle, Anna L K Gonye, Samuel S Freeman, et al.
American Journal of Human Genetics|June 23, 2023
Null and missense mutations of ERI1 cause a recessive phenotypic dichotomy in humansLong Guo, Smrithi Salian, Jing-Yi Xue, et al.
International Journal of Epidemiology|January 9, 2022
Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney diseaseJie Zheng, Yuemiao Zhang, Humaira Rasheed, et al.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
Nature|November 7, 2024
Immune responses in checkpoint myocarditis across heart, blood and tumourSteven M Blum, Daniel A Zlotoff, Neal P Smith, et al.
Research Square|August 13, 2025
Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer's disease and candidate genetic biomarkers for treatment stratificationSathyaseelan Chakkarai, Michal Sadowski, Qiong Yang, et al.
Science Immunology|October 15, 2021
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Biorxiv : the Preprint Server for Biology|November 11, 2020
Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patientsMichael R Filbin, Arnav Mehta, Alexis M Schneider, et al.
Genome Medicine|December 17, 2025
Genetic liability to psoriasis predicts severe disease outcomesJake R Saklatvala, Samuel Lessard, Maris Teder-Laving, et al.
Pageof 128

Showing results (1241-1250 of 1,275) with videos related to

Sort By:
Pageof 128
Cell Reports. Medicine|October 8, 2022
Longitudinal characterization of circulating neutrophils uncovers phenotypes associated with severity in hospitalized COVID-19 patientsThomas J LaSalle, Anna L K Gonye, Samuel S Freeman, et al.
American Journal of Human Genetics|June 23, 2023
Null and missense mutations of ERI1 cause a recessive phenotypic dichotomy in humansLong Guo, Smrithi Salian, Jing-Yi Xue, et al.
International Journal of Epidemiology|January 9, 2022
Trans-ethnic Mendelian-randomization study reveals causal relationships between cardiometabolic factors and chronic kidney diseaseJie Zheng, Yuemiao Zhang, Humaira Rasheed, et al.
Nephron|June 20, 2015
A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR)Fernando C Fervenza, Pietro A Canetta, Sean J Barbour, et al.
Nature|November 7, 2024
Immune responses in checkpoint myocarditis across heart, blood and tumourSteven M Blum, Daniel A Zlotoff, Neal P Smith, et al.
Research Square|August 13, 2025
Cross-tissue omics-guided drug repurposing triangulates novel targetable mechanisms for Alzheimer's disease and candidate genetic biomarkers for treatment stratificationSathyaseelan Chakkarai, Michal Sadowski, Qiong Yang, et al.
Science Immunology|October 15, 2021
Early cross-coronavirus reactive signatures of humoral immunity against COVID-19Paulina Kaplonek, Chuangqi Wang, Yannic Bartsch, et al.
The New England Journal of Medicine|July 4, 2019
Rituximab or Cyclosporine in the Treatment of Membranous NephropathyFernando C Fervenza, Gerald B Appel, Sean J Barbour, et al.
Biorxiv : the Preprint Server for Biology|November 11, 2020
Plasma proteomics reveals tissue-specific cell death and mediators of cell-cell interactions in severe COVID-19 patientsMichael R Filbin, Arnav Mehta, Alexis M Schneider, et al.
Genome Medicine|December 17, 2025
Genetic liability to psoriasis predicts severe disease outcomesJake R Saklatvala, Samuel Lessard, Maris Teder-Laving, et al.
Pageof 128